A Second Look: Prime editing compared to CRISPR/Cas9 gene editing and its potential in future therapeutics

Executed on:May 24, 2024 3:00 PM EDT

Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert

Institution: The Rockefeller UniversityProfessor at The Rockefeller University and Investigator at Howard Hughes Medical Institute
Honored for his pioneering research on the study of CRISPR-Cas systems as one of the first investigators to characterize the function of CRISPR-Cas in bacteria (Marraffini and Sontheimer, Science 2008) and to apply CRISPR-Cas9 for genome editing of human and bacterial cells.
His research investigates how CRISPR-Cas systems provide adaptive immunity to bacteria and helped lay the groundwork for the newly FDA-approved CRISPR-based therapy for sickle cell anemia.

Interview Goal

On this call we will discussing the science behind Prime editing on a molecular level and comparing it to current gene editing methods.

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.